Cargando…
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes
Hyperuricemia and gout have been linked to an increased risk for cardiovascular (CV) disease, stroke, hypertension, heart failure, and chronic kidney disease, possibly through a proinflammatory milieu. However, not all the drugs used in gout treatment improve CV outcomes; colchicine has shown improv...
Autores principales: | Kaul, Subuhi, Gupta, Manasvi, Bandyopadhyay, Dhrubajyoti, Hajra, Adrija, Deedwania, Prakash, Roddy, Edward, Mamas, Mamas, Klein, Allan, Lavie, Carl J., Fonarow, Gregg C., Ghosh, Raktim K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768268/ https://www.ncbi.nlm.nih.gov/pubmed/33369719 http://dx.doi.org/10.1007/s40256-020-00459-1 |
Ejemplares similares
-
COVID-19 Pandemic: Cardiovascular Complications and Future Implications
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2020) -
Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis
por: Tummala, Ramyashree, et al.
Publicado: (2022) -
Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2018) -
COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis
por: Isath, Ameesh, et al.
Publicado: (2023) -
Novel imaging modalities to predict the development of atrial fibrillation post stroke
por: Faisaluddin, Mohammed, et al.
Publicado: (2018)